Medirom Healthcare Technologies (MRM) Shares Outstanding (Weighted Average) (2019 - 2024)
Medirom Healthcare Technologies has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $33595.4 for Q4 2024.
- Quarterly results put Shares Outstanding (Weighted Average) at $33595.4 for Q4 2024, up 1.71% from a year ago — trailing twelve months through Dec 2024 was $33595.4 (up 1.71% YoY), and the annual figure for FY2024 was $33595.4, up 1.71%.
- Shares Outstanding (Weighted Average) for Q4 2024 was $33595.4 at Medirom Healthcare Technologies, up from $33031.3 in the prior quarter.
- Over the last five years, Shares Outstanding (Weighted Average) for MRM hit a ceiling of $42907.8 in Q4 2021 and a floor of $33031.3 in Q4 2023.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $34523.8 (2022), compared with a mean of $36515.0.
- Biggest five-year swings in Shares Outstanding (Weighted Average): increased 11.71% in 2020 and later fell 19.54% in 2022.
- Medirom Healthcare Technologies' Shares Outstanding (Weighted Average) stood at $38516.5 in 2020, then grew by 11.4% to $42907.8 in 2021, then dropped by 19.54% to $34523.8 in 2022, then fell by 4.32% to $33031.3 in 2023, then increased by 1.71% to $33595.4 in 2024.
- The last three reported values for Shares Outstanding (Weighted Average) were $33595.4 (Q4 2024), $33031.3 (Q4 2023), and $34523.8 (Q4 2022) per Business Quant data.